Global Pharma & Cosmetics

Pharma & Cosmetics Comprehensive Study by Distribution Channel (Supermarket, Onlien Stores, Cosmetics Stores, Drug Stores), Cosmetics (Skincare, Haircare, Oral Care, Others), Pharmaceutical (Tablets, Cream, Syrup, Gels, Others), End User (Woman, Men) Players and Region - Global Market Outlook to 2028

Pharma & Cosmetics Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Pharma & cosmetics include the pharmaceutical and cosmetics industry and the range of products included in it. The pharma deals with the drug research, production, and commercial of pharmaceutical products. The cosmetics consist of products developed for cleaning, curing, and managing skincare, haircare, and oral care, it also includes beauty preparations and grooming aids. The pharma & cosmetics involves personal care and healthcare products ranges.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledMerck & Co., Inc. (United States), Pfizer Inc. (United States), Sanofi S.A. (France), Johnson & Johnson (United States), F. Hoffmann-La Roche AG (Switzerland), Novartis International AG (Switzerland), L'Oréal S.A. (France), Estée Lauder Companies Inc. (United States), Shiseido Company (Japan), Eli Lilly and Company (United States), GlaxoSmithKline plc (United Kingdom), AbbVie (United States) and Beiersdorf AG (Germany)


This growth is primarily driven by Rising Prevalence of the Skin Related Issues in People, Need for Curing the Various Type of Diseases and Health-related Problems and Demand for Cosmetics in Haircare and Skincare.

Globally, a noticeable market trend is evident Consumption of Cosmetics Among Women is High Major Players, such as Merck & Co., Inc. (United States), Pfizer Inc. (United States), Sanofi S.A. (France), Johnson & Johnson (United States), F. Hoffmann-La Roche AG (Switzerland), Novartis International AG (Switzerland), L'Oréal S.A. (France), Estée Lauder Companies Inc. (United States), Shiseido Company (Japan), Eli Lilly and Company (United States), GlaxoSmithKline plc (United Kingdom), AbbVie (United States) and Beiersdorf AG (Germany), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

27th June 2019, AbbVie to acquire Allergan in a multibillion-dollar merger. The new company will retain AbbVie’s US headquarters, bringing Allergan back to its home country; there are now no tax advantages in being headquartered in Ireland. The acquisition of Allergan represents a rare and unique opportunity for AbbVie to accelerate the progress of the growth platform by adding highly valuable assets with leadership positions across the growth segments

Regulatory Insights:
"Under the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market. Drugs, however, must generally either receive premarket approval by FDA through the New Drug Application (NDA) process or conform to a "monograph" for a particular drug category, as established by FDA's Over-the-Counter (OTC) Drug Review. These monographs specify conditions whereby OTC drug ingredients are generally recognized as safe and effective, and not misbranded."

Influencing Trend:
Consumption of Cosmetics Among Women is High and Advancement in the Packaging of Pharma & Cosmetics

Market Growth Drivers:
Rising Prevalence of the Skin Related Issues in People, Need for Curing the Various Type of Diseases and Health-related Problems and Demand for Cosmetics in Haircare and Skincare

Challenges:
Stringent Regulatory Guidelines and Standards on the Packaging Labeling of Pharma & Cosmetics

Restraints:
Side Affects and Allergy-Related Risks Involved in Pharma & Cosmetics and High Cost Involved in Cosmetics Products

Opportunities:
Surging Investment in the Research and Development in Pharma & Cosmetics and Rising Spendings of People on Pharma & Cosmetics

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Pharma & Cosmetics Market
- Analysis about New Entrants in Pharma & Cosmetics Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Pharma & Cosmetics Study Sheds Light on
— The Pharma & Cosmetics Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Pharma & Cosmetics industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Pharma & Cosmetics industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Distribution Channel
  • Supermarket
  • Onlien Stores
  • Cosmetics Stores
  • Drug Stores

By Cosmetics
  • Skincare
  • Haircare
  • Oral Care
  • Others

By Pharmaceutical
  • Tablets
  • Cream
  • Syrup
  • Gels
  • Others

By End User
  • Woman
  • Men

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of the Skin Related Issues in People
      • 3.2.2. Need for Curing the Various Type of Diseases and Health-related Problems
      • 3.2.3. Demand for Cosmetics in Haircare and Skincare
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Guidelines and Standards on the Packaging Labeling of Pharma & Cosmetics
    • 3.4. Market Trends
      • 3.4.1. Consumption of Cosmetics Among Women is High
      • 3.4.2. Advancement in the Packaging of Pharma & Cosmetics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharma & Cosmetics, by Distribution Channel, Cosmetics, Pharmaceutical, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharma & Cosmetics (Value)
      • 5.2.1. Global Pharma & Cosmetics by: Distribution Channel (Value)
        • 5.2.1.1. Supermarket
        • 5.2.1.2. Onlien Stores
        • 5.2.1.3. Cosmetics Stores
        • 5.2.1.4. Drug Stores
      • 5.2.2. Global Pharma & Cosmetics by: Cosmetics (Value)
        • 5.2.2.1. Skincare
        • 5.2.2.2. Haircare
        • 5.2.2.3. Oral Care
        • 5.2.2.4. Others
      • 5.2.3. Global Pharma & Cosmetics by: Pharmaceutical (Value)
        • 5.2.3.1. Tablets
        • 5.2.3.2. Cream
        • 5.2.3.3. Syrup
        • 5.2.3.4. Gels
        • 5.2.3.5. Others
      • 5.2.4. Global Pharma & Cosmetics by: End User (Value)
        • 5.2.4.1. Woman
        • 5.2.4.2. Men
      • 5.2.5. Global Pharma & Cosmetics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Pharma & Cosmetics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co., Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sanofi S.A. (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Johnson & Johnson (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis International AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. L'Oréal S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Estée Lauder Companies Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Shiseido Company (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Eli Lilly and Company (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. GlaxoSmithKline plc (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. AbbVie (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Beiersdorf AG (Germany)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Pharma & Cosmetics Sale, by Distribution Channel, Cosmetics, Pharmaceutical, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharma & Cosmetics (Value)
      • 7.2.1. Global Pharma & Cosmetics by: Distribution Channel (Value)
        • 7.2.1.1. Supermarket
        • 7.2.1.2. Onlien Stores
        • 7.2.1.3. Cosmetics Stores
        • 7.2.1.4. Drug Stores
      • 7.2.2. Global Pharma & Cosmetics by: Cosmetics (Value)
        • 7.2.2.1. Skincare
        • 7.2.2.2. Haircare
        • 7.2.2.3. Oral Care
        • 7.2.2.4. Others
      • 7.2.3. Global Pharma & Cosmetics by: Pharmaceutical (Value)
        • 7.2.3.1. Tablets
        • 7.2.3.2. Cream
        • 7.2.3.3. Syrup
        • 7.2.3.4. Gels
        • 7.2.3.5. Others
      • 7.2.4. Global Pharma & Cosmetics by: End User (Value)
        • 7.2.4.1. Woman
        • 7.2.4.2. Men
      • 7.2.5. Global Pharma & Cosmetics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharma & Cosmetics: by Distribution Channel(USD Million)
  • Table 2. Pharma & Cosmetics Supermarket , by Region USD Million (2017-2022)
  • Table 3. Pharma & Cosmetics Onlien Stores , by Region USD Million (2017-2022)
  • Table 4. Pharma & Cosmetics Cosmetics Stores , by Region USD Million (2017-2022)
  • Table 5. Pharma & Cosmetics Drug Stores , by Region USD Million (2017-2022)
  • Table 6. Pharma & Cosmetics: by Cosmetics(USD Million)
  • Table 7. Pharma & Cosmetics Skincare , by Region USD Million (2017-2022)
  • Table 8. Pharma & Cosmetics Haircare , by Region USD Million (2017-2022)
  • Table 9. Pharma & Cosmetics Oral Care , by Region USD Million (2017-2022)
  • Table 10. Pharma & Cosmetics Others , by Region USD Million (2017-2022)
  • Table 11. Pharma & Cosmetics: by Pharmaceutical(USD Million)
  • Table 12. Pharma & Cosmetics Tablets , by Region USD Million (2017-2022)
  • Table 13. Pharma & Cosmetics Cream , by Region USD Million (2017-2022)
  • Table 14. Pharma & Cosmetics Syrup , by Region USD Million (2017-2022)
  • Table 15. Pharma & Cosmetics Gels , by Region USD Million (2017-2022)
  • Table 16. Pharma & Cosmetics Others , by Region USD Million (2017-2022)
  • Table 17. Pharma & Cosmetics: by End User(USD Million)
  • Table 18. Pharma & Cosmetics Woman , by Region USD Million (2017-2022)
  • Table 19. Pharma & Cosmetics Men , by Region USD Million (2017-2022)
  • Table 20. South America Pharma & Cosmetics, by Country USD Million (2017-2022)
  • Table 21. South America Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 22. South America Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 23. South America Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 24. South America Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 25. Brazil Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 26. Brazil Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 27. Brazil Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 28. Brazil Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 29. Argentina Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 30. Argentina Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 31. Argentina Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 32. Argentina Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 33. Rest of South America Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 34. Rest of South America Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 35. Rest of South America Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 36. Rest of South America Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 37. Asia Pacific Pharma & Cosmetics, by Country USD Million (2017-2022)
  • Table 38. Asia Pacific Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 39. Asia Pacific Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 40. Asia Pacific Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 41. Asia Pacific Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 42. China Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 43. China Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 44. China Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 45. China Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 46. Japan Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 47. Japan Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 48. Japan Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 49. Japan Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 50. India Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 51. India Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 52. India Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 53. India Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 54. South Korea Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 55. South Korea Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 56. South Korea Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 57. South Korea Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 58. Taiwan Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 59. Taiwan Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 60. Taiwan Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 61. Taiwan Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 62. Australia Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 63. Australia Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 64. Australia Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 65. Australia Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 70. Europe Pharma & Cosmetics, by Country USD Million (2017-2022)
  • Table 71. Europe Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 72. Europe Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 73. Europe Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 74. Europe Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 75. Germany Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 76. Germany Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 77. Germany Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 78. Germany Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 79. France Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 80. France Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 81. France Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 82. France Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 83. Italy Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 84. Italy Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 85. Italy Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 86. Italy Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 87. United Kingdom Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 88. United Kingdom Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 89. United Kingdom Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 90. United Kingdom Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 91. Netherlands Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 92. Netherlands Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 93. Netherlands Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 94. Netherlands Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 95. Rest of Europe Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 96. Rest of Europe Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 97. Rest of Europe Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 98. Rest of Europe Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 99. MEA Pharma & Cosmetics, by Country USD Million (2017-2022)
  • Table 100. MEA Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 101. MEA Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 102. MEA Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 103. MEA Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 104. Middle East Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 105. Middle East Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 106. Middle East Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 107. Middle East Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 108. Africa Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 109. Africa Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 110. Africa Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 111. Africa Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 112. North America Pharma & Cosmetics, by Country USD Million (2017-2022)
  • Table 113. North America Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 114. North America Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 115. North America Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 116. North America Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 117. United States Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 118. United States Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 119. United States Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 120. United States Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 121. Canada Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 122. Canada Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 123. Canada Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 124. Canada Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 125. Mexico Pharma & Cosmetics, by Distribution Channel USD Million (2017-2022)
  • Table 126. Mexico Pharma & Cosmetics, by Cosmetics USD Million (2017-2022)
  • Table 127. Mexico Pharma & Cosmetics, by Pharmaceutical USD Million (2017-2022)
  • Table 128. Mexico Pharma & Cosmetics, by End User USD Million (2017-2022)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Pharma & Cosmetics: by Distribution Channel(USD Million)
  • Table 143. Pharma & Cosmetics Supermarket , by Region USD Million (2023-2028)
  • Table 144. Pharma & Cosmetics Onlien Stores , by Region USD Million (2023-2028)
  • Table 145. Pharma & Cosmetics Cosmetics Stores , by Region USD Million (2023-2028)
  • Table 146. Pharma & Cosmetics Drug Stores , by Region USD Million (2023-2028)
  • Table 147. Pharma & Cosmetics: by Cosmetics(USD Million)
  • Table 148. Pharma & Cosmetics Skincare , by Region USD Million (2023-2028)
  • Table 149. Pharma & Cosmetics Haircare , by Region USD Million (2023-2028)
  • Table 150. Pharma & Cosmetics Oral Care , by Region USD Million (2023-2028)
  • Table 151. Pharma & Cosmetics Others , by Region USD Million (2023-2028)
  • Table 152. Pharma & Cosmetics: by Pharmaceutical(USD Million)
  • Table 153. Pharma & Cosmetics Tablets , by Region USD Million (2023-2028)
  • Table 154. Pharma & Cosmetics Cream , by Region USD Million (2023-2028)
  • Table 155. Pharma & Cosmetics Syrup , by Region USD Million (2023-2028)
  • Table 156. Pharma & Cosmetics Gels , by Region USD Million (2023-2028)
  • Table 157. Pharma & Cosmetics Others , by Region USD Million (2023-2028)
  • Table 158. Pharma & Cosmetics: by End User(USD Million)
  • Table 159. Pharma & Cosmetics Woman , by Region USD Million (2023-2028)
  • Table 160. Pharma & Cosmetics Men , by Region USD Million (2023-2028)
  • Table 161. South America Pharma & Cosmetics, by Country USD Million (2023-2028)
  • Table 162. South America Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 163. South America Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 164. South America Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 165. South America Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 166. Brazil Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 167. Brazil Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 168. Brazil Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 169. Brazil Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 170. Argentina Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 171. Argentina Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 172. Argentina Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 173. Argentina Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 174. Rest of South America Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 175. Rest of South America Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 176. Rest of South America Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 177. Rest of South America Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 178. Asia Pacific Pharma & Cosmetics, by Country USD Million (2023-2028)
  • Table 179. Asia Pacific Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 180. Asia Pacific Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 181. Asia Pacific Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 182. Asia Pacific Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 183. China Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 184. China Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 185. China Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 186. China Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 187. Japan Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 188. Japan Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 189. Japan Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 190. Japan Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 191. India Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 192. India Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 193. India Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 194. India Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 195. South Korea Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 196. South Korea Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 197. South Korea Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 198. South Korea Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 199. Taiwan Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 200. Taiwan Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 201. Taiwan Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 202. Taiwan Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 203. Australia Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 204. Australia Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 205. Australia Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 206. Australia Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 207. Rest of Asia-Pacific Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 208. Rest of Asia-Pacific Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 209. Rest of Asia-Pacific Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 210. Rest of Asia-Pacific Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 211. Europe Pharma & Cosmetics, by Country USD Million (2023-2028)
  • Table 212. Europe Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 213. Europe Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 214. Europe Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 215. Europe Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 216. Germany Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 217. Germany Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 218. Germany Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 219. Germany Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 220. France Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 221. France Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 222. France Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 223. France Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 224. Italy Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 225. Italy Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 226. Italy Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 227. Italy Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 228. United Kingdom Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 229. United Kingdom Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 230. United Kingdom Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 231. United Kingdom Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 232. Netherlands Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 233. Netherlands Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 234. Netherlands Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 235. Netherlands Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 236. Rest of Europe Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 237. Rest of Europe Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 238. Rest of Europe Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 239. Rest of Europe Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 240. MEA Pharma & Cosmetics, by Country USD Million (2023-2028)
  • Table 241. MEA Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 242. MEA Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 243. MEA Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 244. MEA Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 245. Middle East Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 246. Middle East Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 247. Middle East Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 248. Middle East Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 249. Africa Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 250. Africa Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 251. Africa Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 252. Africa Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 253. North America Pharma & Cosmetics, by Country USD Million (2023-2028)
  • Table 254. North America Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 255. North America Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 256. North America Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 257. North America Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 258. United States Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 259. United States Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 260. United States Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 261. United States Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 262. Canada Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 263. Canada Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 264. Canada Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 265. Canada Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 266. Mexico Pharma & Cosmetics, by Distribution Channel USD Million (2023-2028)
  • Table 267. Mexico Pharma & Cosmetics, by Cosmetics USD Million (2023-2028)
  • Table 268. Mexico Pharma & Cosmetics, by Pharmaceutical USD Million (2023-2028)
  • Table 269. Mexico Pharma & Cosmetics, by End User USD Million (2023-2028)
  • Table 270. Research Programs/Design for This Report
  • Table 271. Key Data Information from Secondary Sources
  • Table 272. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharma & Cosmetics: by Distribution Channel USD Million (2017-2022)
  • Figure 5. Global Pharma & Cosmetics: by Cosmetics USD Million (2017-2022)
  • Figure 6. Global Pharma & Cosmetics: by Pharmaceutical USD Million (2017-2022)
  • Figure 7. Global Pharma & Cosmetics: by End User USD Million (2017-2022)
  • Figure 8. South America Pharma & Cosmetics Share (%), by Country
  • Figure 9. Asia Pacific Pharma & Cosmetics Share (%), by Country
  • Figure 10. Europe Pharma & Cosmetics Share (%), by Country
  • Figure 11. MEA Pharma & Cosmetics Share (%), by Country
  • Figure 12. North America Pharma & Cosmetics Share (%), by Country
  • Figure 13. Global Pharma & Cosmetics share by Players 2022 (%)
  • Figure 14. Global Pharma & Cosmetics share by Players (Top 3) 2022(%)
  • Figure 15. Global Pharma & Cosmetics share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 19. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 22. Sanofi S.A. (France) Revenue: by Geography 2022
  • Figure 23. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 24. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 25. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2022
  • Figure 27. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis International AG (Switzerland) Revenue: by Geography 2022
  • Figure 29. L'Oréal S.A. (France) Revenue, Net Income and Gross profit
  • Figure 30. L'Oréal S.A. (France) Revenue: by Geography 2022
  • Figure 31. Estée Lauder Companies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Estée Lauder Companies Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Shiseido Company (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Shiseido Company (Japan) Revenue: by Geography 2022
  • Figure 35. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Eli Lilly and Company (United States) Revenue: by Geography 2022
  • Figure 37. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2022
  • Figure 39. AbbVie (United States) Revenue, Net Income and Gross profit
  • Figure 40. AbbVie (United States) Revenue: by Geography 2022
  • Figure 41. Beiersdorf AG (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Beiersdorf AG (Germany) Revenue: by Geography 2022
  • Figure 43. Global Pharma & Cosmetics: by Distribution Channel USD Million (2023-2028)
  • Figure 44. Global Pharma & Cosmetics: by Cosmetics USD Million (2023-2028)
  • Figure 45. Global Pharma & Cosmetics: by Pharmaceutical USD Million (2023-2028)
  • Figure 46. Global Pharma & Cosmetics: by End User USD Million (2023-2028)
  • Figure 47. South America Pharma & Cosmetics Share (%), by Country
  • Figure 48. Asia Pacific Pharma & Cosmetics Share (%), by Country
  • Figure 49. Europe Pharma & Cosmetics Share (%), by Country
  • Figure 50. MEA Pharma & Cosmetics Share (%), by Country
  • Figure 51. North America Pharma & Cosmetics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck & Co., Inc. (United States)
  • Pfizer Inc. (United States)
  • Sanofi S.A. (France)
  • Johnson & Johnson (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Novartis International AG (Switzerland)
  • L'Oréal S.A. (France)
  • Estée Lauder Companies Inc. (United States)
  • Shiseido Company (Japan)
  • Eli Lilly and Company (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • AbbVie (United States)
  • Beiersdorf AG (Germany)
Select User Access Type

Key Highlights of Report


May 2023 204 Pages 73 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharma & Cosmetics Quantitative research analysis
Global Pharma & Cosmetics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Pharma & Cosmetics market are Merck & Co., Inc. (United States), Pfizer Inc. (United States), Sanofi S.A. (France), Johnson & Johnson (United States), F. Hoffmann-La Roche AG (Switzerland), Novartis International AG (Switzerland), L'Oréal S.A. (France), Estée Lauder Companies Inc. (United States), Shiseido Company (Japan), Eli Lilly and Company (United States), GlaxoSmithKline plc (United Kingdom), AbbVie (United States) and Beiersdorf AG (Germany), to name a few.
is dominating the Pharma & Cosmetics Market.
"Stringent Regulatory Guidelines and Standards on the Packaging Labeling of Pharma & Cosmetics" is seen as one of the major challenges by many Industry Players of Pharma & Cosmetics Market
The Pharma & Cosmetics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Pharma & Cosmetics market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Pharma & Cosmetics Report?

Have a Query? Click Here

Other Related Reports

Contrast Agents Comprehensive Study by Type (Iodine-based, Barium-Sulfate, Gadolinium), Application (Interventional Radiology, Interventional Cardiology), Route of Administration (Intravenously/intra...
$ 3750
Skin Adhesives Comprehensive Study by Application (Ophthalmic Surgery, ENT Surgery, Dental Surgery, General Surgery, Plastic Surgery, Gynaecology, Gastroenterology, Orthopaedic, Surgical oncology, Ot...
$ 3650
Left Ventricular Dysfunction Drug Comprehensive Study by Type (BAY-1142524, CAP-1002, Carvedilol CR, CTX-101, Omecamtiv Mecarbil, Others), Application (Hospital, Clinic, Others), Drug Type (Prescript...
$ 3450
Animal Parasiticides - Comprehensive Study by Type (Endoparasiticides (Oral, Injectables), Ectoparasiticides (Sprays, Pour On, Spot On), Endectocides), Application (Agriculture, Horticulture), Form (...
$ 3350
Guillain-Barre Syndrome Drugs Comprehensive Study by Type (Coversin, Immune Globulin, Others), Application (Clinic, Hospital, Others), Forms (Tablets, Injection), Distribution Channel (Hospital Pharm...
$ 3350
Burkholderia Pseudomallei Infections Drug Comprehensive Study by Type (Cholinesterase inhibitors, Memantine), Application (Reduce Fever, Improves Breathing Conditions, Others), Distribution Channel (...
$ 3650